Literature DB >> 11604318

Expression systems for use in actinomycetes and related organisms.

N D Connell1.   

Abstract

There have been significant advances in genetic and molecular approaches to understanding the physiology of organisms belonging to the genera Mycobacterium, Corynebacterium, Nocardia and Streptomyces. This review discusses recent advances in heterologous protein expression in members of the actinomycete group, including codon usage, post-translational modification and inducible gene expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11604318     DOI: 10.1016/s0958-1669(00)00243-3

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  5 in total

Review 1.  On the way toward regulatable expression systems in acetic acid bacteria: target gene expression and use cases.

Authors:  Philipp Moritz Fricke; Angelika Klemm; Michael Bott; Tino Polen
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-15       Impact factor: 4.813

2.  mRNA differential display in a microbial enrichment culture: simultaneous identification of three cyclohexanone monooxygenases from three species.

Authors:  Patricia C Brzostowicz; Dana M Walters; Stuart M Thomas; Vasantha Nagarajan; Pierre E Rouvière
Journal:  Appl Environ Microbiol       Date:  2003-01       Impact factor: 4.792

3.  Actinomycetes as host cells for production of recombinant proteins.

Authors:  Nobutaka Nakashima; Yasuo Mitani; Tomohiro Tamura
Journal:  Microb Cell Fact       Date:  2005-03-23       Impact factor: 5.328

4.  Bacterial cell factories for recombinant protein production; expanding the catalogue.

Authors:  Neus Ferrer-Miralles; Antonio Villaverde
Journal:  Microb Cell Fact       Date:  2013-11-18       Impact factor: 5.328

5.  A tunable L-arabinose-inducible expression plasmid for the acetic acid bacterium Gluconobacter oxydans.

Authors:  Philipp Moritz Fricke; Tobias Link; Jochem Gätgens; Christiane Sonntag; Maike Otto; Michael Bott; Tino Polen
Journal:  Appl Microbiol Biotechnol       Date:  2020-09-25       Impact factor: 4.813

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.